Subgroups
Outcomes (4)
- neurology-vestibular-vertigo-severity-level-change-from-baseline-self-reported
- neurology-vestibular-vertigo-severity-level-change-from-baseline-to-end-of-treatment-self-reported
- neurology-vestibular-vertigo-severity-reduction-self-reported
- neurology-vestibular-vertigo-severity-vas-0-to-100-mm-self-reported
Protocols & scoring
medication-betahistine-oral-daily-two-month1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| neurology-vestibular-vertigo-severity-level-change-from-baseline-to-end-of-treatment-self-reported | +85 | 40 | 305 |
medication-betahistine-oral-daily-vestibular-vertigo1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| neurology-vestibular-vertigo-severity-level-change-from-baseline-self-reported | +80 | 30 | 305 |
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| neurology-vestibular-vertigo-severity-vas-0-to-100-mm-self-reported | +75 | 60 | 30 |
medication-vertigo-acute-emergency-meclizine-ondansetron1 evidence row
| Outcome | Effect | Confidence | N |
|---|---|---|---|
| neurology-vestibular-vertigo-severity-reduction-self-reported | +15 | 20 | 1 |
Path: neurology › vestibular › vertigo › severity